Vancouver Prostate Centre

Vancouver, British Columbia V5Z1M9

3 studies enrolling now · 8 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, Bladder Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Non Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Superficial Bladder Cancer, Urologic Cancer, Urothelial Carcinoma

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer — Recruiting now
• Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer — Recruiting now
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed